Company ICON Public Limited Company

Equities

ICLR

IE0005711209

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 04:00:00 2024-12-04 pm EST			5-day change	1st Jan Change
214.50 ^USD	+0.71%		+0.78%	-24.22%

Dec. 02	Nephron Upgrades ICON to Buy, Price Target is $280	MT
Nov. 25	Fed minutes and inflation data set to stir Thanksgiving week

Business description: ICON Public Limited Company

ICON Public Limited Company is a healthcare intelligence and clinical research organization. The Company is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. It offers a range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. The Company's services include clinical research services, commercial positioning, consulting, early phase, strategic solutions, laboratories, language services, medical imaging, real world intelligence, site and patient solutions, COVID-19 clinical operation and decentralized and hybrid clinical solutions. It also provides its full range of clinical, consulting and commercial services across several sectors, which include biosimilars, biotechnology, government and public health solutions, medical devices and pharmaceuticals.

Number of employees: 42,250

Sales by Activity: ICON Public Limited Company

Fiscal Period: December	2019	2020	2021	2022	2023
Medical Labs & Research	2.81B	2.8B	5.48B	7.74B	8.12B

See all business segments

Geographical breakdown of sales: ICON Public Limited Company

Fiscal Period: December	2019	2020	2021	2022	2023
United States (U.S.)	892M	926M	2.58B	3.57B	3.28B
Ireland	1.25B	1.18B	1.37B	1.98B	2.38B
Rest of Europe	389M	417M	1.18B	1.62B	1.57B
Rest of world	272M	274M	358M	564M	884M

See all geographic segments

Managers: ICON Public Limited Company

Director	Title	Age	Since
Stephen Cutler CEO	Chief Executive Officer	63	2017-02-28
Nigel Bernard John Clerkin DFI	Director of Finance/CFO	51	2024-09-30
Gregory Licholai CTO	Chief Tech/Sci/R&D Officer	59	2021-10-31
Tom O'Leary CTO	Chief Tech/Sci/R&D Officer	-	-
Diarmaid Cunningham ADM	Chief Administrative Officer	49	2016-06-30

See ICON PUBLIC LIMITED COMPANY governance

Members of the board: ICON Public Limited Company

Manager	Title	Age	Since
John Climax CHM	Chairman	71	2002-10-31
Ciaran Murray CHM	Chairman	61	2017-02-28
Stephen Cutler BRD	Director/Board Member	63	2015-11-24
Eugene McCague BRD	Director/Board Member	65	2017-10-03
Rónán Murphy BRD	Director/Board Member	66	2016-10-17
Julie O'Neill BRD	Director/Board Member	58	2019-07-22
Linda Grais BRD	Director/Board Member	68	2021-06-30
Anne Michelle Whitaker BRD	Director/Board Member	56	2024-07-22

Composition of the Board of Directors

Shareholders: ICON Public Limited Company

Name	Equities	%	Valuation
WCM Investment Management LLC 8.060 %	6,654,257	8.060 %	1 478 M $
Massachusetts Financial Services Co. 4.922 %	4,063,771	4.922 %	903 M $
T. Rowe Price International Ltd. 4.058 %	3,350,582	4.058 %	744 M $
Wellington Trust Co., NA 3.733 %	3,081,973	3.733 %	685 M $
Ninety One UK Ltd. 3.266 %	2,696,402	3.266 %	599 M $

List of ICON PUBLIC LIMITED COMPANY shareholders

Company details: ICON Public Limited Company

ICON plc

South County Business Park Leopardstown

18, Dublin

+353 1 291 2000

http://www.iconplc.com

address ICON Public Limited Company(ICLR)

Group companies: ICON Public Limited Company

Name	Category and Sector
ICON Clinical Research India Pvt Ltd. ICON Clinical Research India Pvt Ltd. Miscellaneous Commercial ServicesCommercial Services Part of ICON plc, ICON Clinical Research India Pvt Ltd. is an Indian company that provides clinical research and development services. The company is based in Chennai, India.	Miscellaneous Commercial Services
ICON Clinical Research Ltd. ICON Clinical Research Ltd. Miscellaneous Commercial ServicesCommercial Services ICON Clinical Research Ltd., a subsidiary of ICON plc, is an Irish company located in Dublin. The firm provides consulting, outsourced development and commercialization services to pharmaceutical, biotechnology, medical device, government and public health organisations.	Miscellaneous Commercial Services
Icon Investments (UK) Ltd.
Icon Luxembourg SARL Icon Luxembourg SARL Finance/Rental/LeasingFinance Part of ICON plc, Icon Luxembourg SARL is a financial institution. The company is based in Luxembourg, Luxembourg. Founded in 1998.	Finance/Rental/Leasing
ICON Investments Five Unlimited Co. ICON Investments Five Unlimited Co. MiscellaneousMiscellaneous Part of ICON plc, ICON Investments Five Unlimited Co. is an investment holding Irish company. The company is based in Dublin, Ireland.	Miscellaneous

See all subsidiaries

Other Biotechnology & Medical Research

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi. ($)
ICON PUBLIC LIMITED COMPANY	-0.27%	+0.40%	-20.92%	-21.93%	17.58B
LONZA GROUP AG	-0.72%	-1.13%	+56.81%	-26.92%	42.79B
IQVIA HOLDINGS INC.	-0.60%	-0.32%	-7.53%	-23.35%	36.41B
CELLTRION, INC.	+1.25%	+6.44%	+14.59%	-5.81%	27.1B
MODERNA, INC.	-3.80%	+1.26%	-46.66%	-86.12%	16.39B
UNITED THERAPEUTICS CORPORATION	-0.36%	-2.18%	+53.20%	+98.28%	16.46B
BIO-TECHNE CORPORATION	-1.28%	+0.24%	+16.23%	-34.19%	11.92B
MEDPACE HOLDINGS, INC.	-0.90%	+1.21%	+23.19%	+64.58%	10.52B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-0.97%	+0.78%	-1.18%	-44.23%	10.19B
TEMPUS AI, INC	-10.57%	-4.37%	-	-	8.86B
Average	-1.26%	+0.02%	+9.75%	-8.85%	19.82B
Weighted average by Cap.	-0.55%	+0.24%	+14.37%	-13.29%